MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/2162402x.2020.1730538

Медицинская библиотека · Oncoimmunology · 2020

Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy.

Georganaki Maria, Ramachandran Mohanraj, Tuit Sander, Núñez Nicolás Gonzalo, Karampatzakis Alexandros, Fotaki Grammatiki, van Hooren Luuk, Huang Hua, Lugano Roberta, Ulas Thomas, Kaunisto Aura, Holland Eric C, Ellmark Peter, Mangsbo Sara M, Schultze Joachim, Essand Magnus, Tugues Sonia, Dimberg Anna

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

CD40-stimulating immunotherapy can elicit potent anti-tumor responses by activating dendritic cells and enhancing T-cell priming. Tumor vessels orchestrate T-cell recruitment during immune response, but the effect of CD40-stimulating immunotherapy on tumor endothelial cells has not been evaluated. Here, we have investigated how tumor endothelial cells transcriptionally respond to CD40-stimulating immunotherapy by isolating tumor endothelial cells from agonistic CD40 mAb- or isotype-treated mice bearing B16-F10 melanoma, and performing RNA-sequencing. Gene set enrichment analysis revealed that agonistic CD40 mAb therapy increased interferon (IFN)-related responses in tumor endothelial cells, including up-regulation of the immunosuppressive enzyme Indoleamine 2, 3-Dioxygenase 1 (IDO1). IDO1 was predominantly expressed in endothelial cells within the tumor microenvironment, and its expression in tumor endothelium was positively correlated to T-cell infiltration and to increased intratumoral expression of IFNγ. In vitro, endothelial cells up-regulated IDO1 in response to T-cell-derived IFNγ, but not in response to CD40-stimulation. Combining agonistic CD40 mAb therapy with the IDO1 inhibitor epacadostat delayed tumor growth in B16-F10 melanoma, associated with increased activation of tumor-infiltrating T-cells. Hereby, we show that the tumor endothelial cells up-regulate IDO1 upon CD40-stimulating immunotherapy in response to increased IFNγ-secretion by T-cells, revealing a novel immunosuppressive feedback mechanism whereby tumor vessels limit T-cell activation.

Для цитирования: Georganaki Maria, Ramachandran Mohanraj, Tuit Sander, Núñez Nicolás Gonzalo, Karampatzakis Alexandros, Fotaki Grammatiki, van Hooren Luuk, Huang Hua, Lugano Roberta, Ulas Thomas, Kaunisto Aura, Holland Eric C, Ellmark Peter, Mangsbo Sara M, Schultze Joachim, Essand Magnus, Tugues Sonia, Dimberg Anna. Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy.. Oncoimmunology. 2020. DOI: 10.1080/2162402x.2020.1730538.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.